Gilead gets FDA approval in oncology, Bio-Techne acquires Asuragen, AI for tumor targeting, and Achilles completes $175M IPO. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://tinyurl.com/Niche-044-1https://tinyurl.com/Niche-044-2https://tinyurl.com/Niche-044-3https://tinyurl.com/Niche-044-4 Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodson…
Charles River acquires Retrogenix, IQVIA fully acquires Q2 Solutions, Agios sells $1.8B in oncology, and Alloy forges a $75M series C. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://tinyurl.com/Niche-043-1https://tinyurl.com/Niche-043-2https://tinyurl.com/Niche-043-3https://tinyurl.com/Niche-043-4https://tinyurl.com/Niche-043-5 Music…
This is our March bonus episode. I sit down with Dr. Benjamin Schwartz an orthopedic surgeon and digital health expert. We talk digital integration, healthcare…
Mergers in precision oncology testing, Medtronic breakthrough valve replacement, Gyroscope raises capital for AMD, and small molecule genetic treatments get $240M IPO. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://tinyurl.com/Niche-041-1https://tinyurl.com/Niche-041-2https://tinyurl.com/Niche-041-3https://tinyurl.com/Niche-041-4…
A new MS therapeutic, Fujifilm picks CDMO facility site, consolidation in medical services, and a new oncology startup. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://tinyurl.com/Niche-040-1https://tinyurl.com/Niche-040-2https://tinyurl.com/Niche-040-3https://tinyurl.com/Niche-040-4 Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodson…
92% reduction in COVID mortality, AVEO gets FDA approval, Takeda acquires Maverick and targets emerging markets, and AgomAb raises $74M Series B for regenerative medicine.…
Amgen nabs Five Prime Therapeutics in $1.9B deal, KemPharm ligates their way out of debt with ADHD, three failed COVID19 pipelines, and Colfax follows 2019…
I sit down with Dr. Mitrani, the Chief Scientific Officer for Organicell, a clinical stage biopharma company focused on regenerative medicine. Their leading product, Zofin…
PRA acquired by Icon, Johnson & Johnson’s vaccine approved, Oncopeptides’ earns FDA approval, Roivant acquires Silicone Therapeutics, and Merck acquires Pandion. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://tinyurl.com/niche-036-1https://tinyurl.com/niche-036-2https://tinyurl.com/niche-036-3https://tinyurl.com/niche-036-4https://tinyurl.com/niche-036-5 Music…
Eli Lilly bets on RIPK1, Charles River spends $875M on cell and gene therapy, Adjuvant Capital gets who’s who in backing, you can now buy…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
